RALEIGH — PRA Health Sciences, with headquarters in Raleigh, announced today a partnership between its subsidiary, Symphony Health, and Datavant that expands the breadth of data available on patients.
The result: a more “holistic view of the patient journey in the commercial market” for life science companies.
Symphony Health’s proprietary Synoma de-identification engine enables integration of complementary data sets from across the health ecosystem using a unique token.
By working closely with Datavant, Symphony Health said it will now be able to give its customers the flexibility to connect data integrated via Synoma to the hundreds of unique data sets available through Datavant.
“Useful data lives in many places, and this partnership will help our customers bring together an even greater amount of data sets for the benefit of their business and the patients whom they serve,” said Doug Fulling, President, Symphony Health, in a statement. “We are committed to creating a comprehensive view of the patient journey using the largest amount of available de-identified data – all to improve the development and delivery of life-changing therapies.”
The collaboration will allow customers “to connect, expand and analyze all relevant data types” – including electronic health records, medical and pharmacy claims, diagnostic lab datasets, demographics, and information from patient wearables and sensors collected during clinical trials.
“Leveraging these integrated data sets, customers can then build bespoke, fit-for-purpose data assets, custom data strategies and develop unique insights for their business with support from PRA and Symphony data experts,” the firm said in its release.
“Symphony’s data, analytics and technology solutions lay at the heart of commercial analytics,” added Travis May, Co-Founder and Chief Executive Officer, Datavant. “For many years, PRA and Symphony have successfully helped their clients navigate a changing healthcare system. And now, by unlocking the power of the open data ecosystem, Symphony’s customers will have access to dramatically more data, and will be able to create tailored data strategies to solve the next generation of healthcare problems.”